Gene Editing in Human Embryos Sparks Ethical Debate
The technology, still far from clinical use, could one day prevent devastating diseases. But critics warn that even these early results may also fuel interest in commercial embryo editing, despite unresolved ethical and safety concerns. Scientists at Columbia University have used a precise gene-editing tool, base editing, to make changes in three disease-linked genes in early-stage human embryos. The goal wasn’t to create pregnancies, but to test the safety and limits of rewr
Scientists at Columbia University used base editing to modify three genes linked to disease in early human embryos. The study aimed to assess the safety and effectiveness of DNA modification at an early stage. The research, not yet peer-reviewed, has sparked controversy over its implications. Some view it as a potential breakthrough for preventing inherited diseases. Others fear it could lead to the development of 'designer babies.' The study has drawn interest from companies involved in embryo screening and genetic research. Critics are concerned about the ethical and safety issues surrounding embryo editing. Researchers emphasize the need for public and regulatory discussions on the topic. The study highlights the potential and risks of gene editing in early human development.
The research raises important ethical and safety questions about the future of genetic modification in human embryos.
📌 Kaynak
Bu haber XML kaynağından derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →